Inventor · disambiguated record
Andrew James Woodhead
Also filed as: WOODHEAD ANDREW J · WOODHEAD ANDREW JAMES
19 granted patents·13 pending applications·178 citations·filing 2003–2019
94Inventor score
Files withASTEX THERAPEUTICS LTD20BERDINI VALERIO3CHESSARI GIANNI3ATEX THERAPEUTICS LTD1CONGREVE MILES STUART1
Top patents by PatentIndex Score
32 records- 0196US7754725B2Dihydroxyphenyl isoindolymethanonesASTEX THERAPEUTICS LTD·Filed 2007·Granted Jul 13, 2010·22 cites·10 claims
- 0295US8106057B2Dihydroxyphenyl isoindolylmethanonesCHESSARI GIANNI·Filed 2010·Granted Jan 31, 2012·19 cites·7 claims
- 0395US7385059B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jun 10, 2008·33 cites·20 claims
- 0492US8101648B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90CHESSARI GIANNI·Filed 2006·Granted Jan 24, 2012·20 cites·18 claims
- 0590US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 0689US8530469B2Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90CHESSARI GIANNI·Filed 2011·Granted Sep 10, 2013·11 cites·21 claims
- 0788US7825140B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Nov 2, 2010·7 cites·19 claims
- 0888US7745638B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Jun 29, 2010·8 cites·23 claims
- 0985US8080666B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2010·Granted Dec 20, 2011·6 cites·19 claims
- 1083US11466016B2Pharmaceutical compoundsOTSUKA PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·2 cites·27 claims
- 1177US8779147B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·14 claims
- 1277US8653084B2Hydrobenzamide derivatives as inhibitors of Hsp90FREDERICKSON MARTYN·Filed 2007·Granted Feb 18, 2014·5 cites·9 claims
- 1375US9428439B2Hydrobenzamide derivatives as inhibitors of Hsp90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Aug 30, 2016·2 cites·11 claims
- 1473US8796244B2Imidazopyridine derivatives as inhibitors of receptor tyrosine kinasesBERDINI VALERIO·Filed 2009·Granted Aug 5, 2014·2 cites·21 claims
- 1573US8779132B2Pharmaceutical compoundsCONGREVE MILES STUART·Filed 2007·Granted Jul 15, 2014·3 cites·8 claims
- 1666US9914719B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 13, 2018·0 cites·21 claims
- 1765US9051278B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Jun 9, 2015·0 cites·24 claims
- 1863US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
- 1955US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 2052US2008194562A1Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk'sASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 2152US2008306069A1Pyrazole Derivatives for the Inhibition of CDK'S and GSK'SASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 2251US2011224203A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2011·Application pending·0 cites
- 2347US2009215777A1Pyrimidine Derivatives As HSP90 InhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 2447US2010093748A1Substituted piperidines having protein kinase inhibiting activityASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 2546US2007105900A1Pharmaceutical compoundsATEX THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 2646US2008167309A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 2745US2009318500A14-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of CancerASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 2844US2008139620A1Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk'sASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 2943US2010160324A1Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3042US2006063782A13-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitorsMURRAY CHRISTOPHER W·Filed 2003·Application pending·0 cites
- 3139US2014288040A1Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infectionASTEX THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
- 3238US9145354B2Pharmaceutical compoundsASTEX THERAPEUTICS LTD·Filed 2012·Granted Sep 29, 2015·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Andrew James Woodhead files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →